Filing Details
- Accession Number:
- 0001127602-19-032642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 17:21:40
- Reporting Period:
- 2019-11-11
- Accepted Time:
- 2019-11-13 17:21:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1210616 | G Ronald Gelbman | 400 Wood Road Braintree MA 02184 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-11 | 6,573 | $45.45 | 54,957 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-11 | 10,353 | $35.50 | 65,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-11 | 16,926 | $118.26 | 48,384 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-11-11 | 6,573 | $0.00 | 6,573 | $45.45 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-11-11 | 10,353 | $0.00 | 10,353 | $35.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-07-24 | 2020-07-24 | No | 4 | M | Direct |
| 0 | 2015-07-23 | 2021-07-23 | No | 4 | M | Direct |
Footnotes
- This number includes unvested restricted stock units previously reported.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.97 to $118.83, inclusive. the reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.
Billionaire Hedge Funds
